Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

AEHR

Live52w high -8.5%

Annual Quarterly

Core line items from AEHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Annual Quarterly

Entity: AEHR TEST SYSTEMS·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-07-06	Q1 2026 2026-02-27	Q4 2025 2025-11-28	Q3 2025 2025-08-29	Annual 2025 2025-05-30
Revenue	$19.06M	$31.17M	$20.85M	$10.97M	$58.97M
Operating Income	Not available	$-12.94M	$-8.71M	$-4.07M	$-5.68M
Net Income	Not available	$-8.52M	$-5.31M	$-2.08M	$-3.91M
EPS (Diluted)	$-0.01	$-0.28	$-0.18	$-0.07	$-0.13
Total Assets	Not available	$157.05M	$148.73M	$144.09M	$148.51M
Total Liabilities	Not available	$18.25M	$17.96M	$21.70M	$25.64M
Cash & Equivalents	Not available	$36.91M	$30.84M	$22.71M	$24.53M
Free Cash Flow OCF − CapEx	Not available	$-7.07M	$-3.31M	$-1.67M	$-12.39M
Shares Outstanding	Not available	30.95M	30.62M	29.88M	29.88M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.

Core line items from AEHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w high -8.5%

Entity: AEHR TEST SYSTEMS·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-07-06	Q1 2026 2026-02-27	Q4 2025 2025-11-28	Q3 2025 2025-08-29	Annual 2025 2025-05-30
Revenue	$19.06M	$31.17M	$20.85M	$10.97M	$58.97M
Operating Income	Not available	$-12.94M	$-8.71M	$-4.07M	$-5.68M
Net Income	Not available	$-8.52M	$-5.31M	$-2.08M	$-3.91M
EPS (Diluted)	$-0.01	$-0.28	$-0.18	$-0.07	$-0.13
Total Assets	Not available	$157.05M	$148.73M	$144.09M	$148.51M
Total Liabilities	Not available	$18.25M	$17.96M	$21.70M	$25.64M
Cash & Equivalents	Not available	$36.91M	$30.84M	$22.71M	$24.53M
Free Cash Flow OCF − CapEx	Not available	$-7.07M	$-3.31M	$-1.67M	$-12.39M
Shares Outstanding	Not available	30.95M	30.62M	29.88M	29.88M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.